Phase 2b RISE-SSc trial reveals potential predictors of response to riociguat in early diffuse cutaneous systemic sclerosis
Once-weekly semaglutide shows promise in reducing weight and pain in obese patients with knee osteoarthritis
New biomarker ratios show promise in early giant cell arteritis detection in patients with polymyalgia rheumatica
